ASAline. B. Sprikkelman

Aline. B. Sprikkelman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aline. B. Sprikkelman has a total of 147 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Maternal influences on infant gut microbiome and health

    by Trishla Sinha, Siobhan Brushett, Asier Fernández-Pato, Sanzhima Garmaeva, Sergio Andreu-Sánchez, Johanne E. Spreckels, Cyrus A. Mallon, Nataliia Kuzub, Milla Brandao Gois, Jiafei Wu, et al.

    The establishment of the infant gut microbiome is critical for later health 1,2 , yet how it is shaped by maternal and early-life factors remains unclear. Here we metagenomically sequenced 4,526 longitudinal faecal samples from 714 mother–infant pairs in the Dutch birth cohort Lifelines NEXT, spanning 12 weeks of pregnancy to 1 year postpartum. We integrated these data with 474 clinical and exposure variables, and with ultra-deep sequencing of breast milk and vaginal microbiomes. We observe that the maternal gut microbiome undergoes only subtle changes during pregnancy and postpartum, influenced by diet, infections and pre-pregnancy smoking. The maternal gut microbiome is a major reservoir for infant gut strains, with only occasional transmission from vaginal and breast milk microbiomes. Mother–infant gut strain sharing is time dependent, and higher maternal gut species abundance increases the likelihood of strain transmission. We find that the maternal gut microbiome is a predictor of infant eczema. Mode of delivery and feeding mode primarily shaped the infant gut microbiome and its functional profiles, with maternal exposures also having a role. Of 585 vaginally delivered infants, 155 were born at home, but home delivery was only moderately associated with infant gut microbiome composition, similar to other birth parameters such as duration of pushing and ruptured membranes. Overall, we highlight the central role of the mother and her microbiome in shaping the infant gut ecosystem and early health outcomes.


  • Open Access

    Multimorbidity and atopic dermatitis in a population-based cohort: severity-dependent association with distinct nonatopic multimorbidity patterns

    by Leon A Miltner, Laura Loman, Josué Almansa Ortiz, Junfen Zhang, Aline B Sprikkelman, Marie L A Schuttelaar

    Background: Atopic dermatitis (AD) has characteristics of a systemic disease due to underlying systemic inflammation, which is supported by reports of various comorbidities. Objectives: To examine the associations between AD and (nonatopic) multimorbidity in a population-based cohort from the northern Netherlands and to identify differences in multimorbidity patterns between participants with multimorbidity and no AD. Methods: We assessed the lifetime prevalence of 52 diseases, from 15 domains, combining data from questionnaires, medication records and clinical assessments within the Lifelines Cohort. Lifetime AD was self-reported, physician-diagnosed and disease severity based on the Patient-Oriented Eczema Measure. Multimorbidity was defined as the lifetime presence of at least two diseases, while nonatopic multimorbidity excluded asthma, rhinitis and food allergy. A composite morbidity score (cMS) indicated the degree of multimorbidity. We analysed associations of AD and AD severity with multimorbidity and cMS using binary and multinomial logistic regression, adjusting for age and sex, and additionally adjusting for socioeconomic and lifestyle factors. Patterns of nonatopic multimorbidity based on disease domains were explored using latent class analysis, stratified by AD presence. Results: Of 37 193 participants, 3242 (8.7%) had AD. The odds for nonatopic multimorbidity were 1.47-fold higher in participants with AD, particularly for those with moderate-to-severe disease (adjusted odds ratio 1.74 vs. 1.41 for mild disease). The association strengthened with higher degrees of nonatopic multimorbidity, reaching 2.09-fold for ≥ 5 diseases. When considering atopic diseases in the definition of multimorbidity and the cMS, the associations with AD were even stronger. Further adjustments for socioeconomic and lifestyle factors were corroborative. We identified five distinct multimorbidity classes among individuals with and without AD, with two differing across the groups. One class, characterized by the orofacial domain, was only present among those with AD, while another class – resembling the metabolic syndrome – had more of a respiratory contribution to AD with further differences regarding cardiometabolic involvement. Conclusions: Participants with AD, especially moderate-to-severe disease, are more likely to experience (nonatopic) multimorbidity and showed unique patterns of nonatopic multimorbidity with regard to orofacial and cardiometabolic diseases. Our findings highlight the importance of promoting awareness for interdisciplinary approaches to managing patients with AD. An author video to accompany this article is available online.


  • Open Access

    Comparison of Double‐Blind and Open Food Challenges for the Diagnosis of Food Allergy in Childhood: The ALDORADO Study

    by Wouter W. de Weger, Aline. B. Sprikkelman, Catherina. E. M. Herpertz, Gerbrich N. van der Meulen, Judith. M. Vonk, Gerard. H. Koppelman, Arvid. W. A. Kamps

    Background: Double‐blind placebo‐controlled food challenge (DBPCFC) is widely regarded as the “gold standard” to diagnose food allergy. Maximum efforts are made to reduce bias, yet DBPCFCs are costly, time‐, and resource‐intensive. Less demanding open food challenges are increasingly used in clinical practice. However, recommendations regarding the use of these challenges are based on low certainty of evidence, and no comparative studies have been performed using the most recent international food challenge guidelines. We hypothesised that the open food challenge is non‐inferior to DBPCFC in children suspected of allergy to cashew nuts, hazelnuts or peanuts.Methods: A total of 63 children, aged 4 years and older, were included if referred for suspected IgE‐mediated allergy to cashew nut, hazelnut, or peanut. All study participants underwent DBPCFC first, followed by an open food challenge for the same food. Challenge outcomes were assessed by predefined criteria into positive, negative, or inconclusive.Results: DBPCFC and open food challenge outcomes were the same for 36/41 (87.8%) patients. Sensitivity and specificity of the open food challenge were 0.91 (95% CI 0.79, 1.03) and 0.83 (95% CI 0.63, 1.01), respectively, with an AUC value of 0.87. Eliciting and stop doses were not significantly different between both food challenges.Conclusion: The Diagnostic accuracy of open food challenge is non‐inferior to that of DBPCFC. This finding implies less demanding open food challenges can be implemented for children from the age of 4 years suspected to be cashew nut, hazelnut, or peanut allergic. Further research is necessary to validate our findings and to investigate the diagnostic accuracy for other major food allergens.


  • Open Access

    Safe selection of children with a suspected food allergy to introduce peanut or tree nuts at home

    by W. W. de Weger, C. E. M. Herpertz, G. N. van der Meulen, H. Bangma, W. Kastelijn, L. van Lente, G. H. Koppelman, A. B. Sprikkelman, A. W. A. Kamps


  • Open Access

    Investigation of novel salivary biomarkers in paediatric food allergy

    by Wouter W. de Weger, Vibeke M. Bruinenberg, Jeroen H. Gerrits, Lidy van Lente, Catherina E. M. Herpertz, Gerbrich N. van der Meulen, Aline B. Sprikkelman, Gerard H. Koppelman, Arvid W. A. Kamps


  • Open Access

    Corrections

    by Brian P. Vickery, Andrea Vereda, Caroline Nilsson, George Du Toit, Wayne G. Shreffler, A. Wesley Burks, Stacie M. Jones, Montserrat Fernández‐Rivas, Katharina Blümchen, Jonathan O', et al.

  • Open Access

    Low health‐related quality of life is associated with declining home introduction of suspected food allergens

    by Wouter W. Weger, Margreet Kunst, Catherina E. M. Herpertz, Gerbrich Meulen, Lidy Lente, Gerard H. Koppelman, Aline B. Sprikkelman, Arvid W. A. Kamps


  • Open Access

    The dilemma of open or double‐blind food challenges in diagnosing food allergy in children: Design of the ALDORADO trial

    by Wouter W. de Weger, Aline B. Sprikkelman, Catherina E. M. Herpertz, Gerbrich N. van der Meulen, Judith M. Vonk, Arvid W. A. Kamps, Gerard H. Koppelman

    Background: It is of major importance to diagnose food allergy accurately. Current guidelines support the use of oral food challenges to do so. The double‐blind placebo‐controlled food challenge (DBPCFC) has been regarded as the ‘gold standard’ for decades. However, DBPCFCs are costly, and time‐ and resource‐intensive procedures. Structural implementation of less demanding open food challenges will only find support if research demonstrates that their outcome is comparable to DBPCFC, yet this has been proven difficult to investigate.Methods: We performed a literature review to investigate the diagnostic accuracy of oral food challenges and interviewed 19 parents of children with proven or suspected food allergy about the design of a trial to study this.Results: An overview of the dilemma of diagnosing food allergy using oral food challenges, and the methodological issues and parents’ opinions to study this. No comparative studies have been performed using the latest guidelines on oral food challenges.Conclusions: There is an urgent need to investigate the diagnostic accuracy of different oral food challenge protocols. We present the rationale and design of the ALDORADO trial (ALlergy Diagnosed by Open oR DOuble‐blind food challenge) that has been set up to investigate whether the outcome of the open food challenge is comparable to DBPCFC.


  • Preventie, diagnostiek en behandeling van koemelkallergie, onderdeel van de JGZ-richtlijn Voedselovergevoeligheid

    by J.E. Kist-Van Holthe, B.J. Vlieg-Boerstra, A.M.W. Bulk-Bunschoten, C.L. Wensing-Souren, A.B. Sprikkelman, C.M.F. Kneepkens, T. Kuijpers, M.L.A. de Kroon, R.A. HiraSing

  • Sa2071 Galectin-9 Induced by Dietary Synbiotics is Involved in Suppression of Allergic Symptoms in Mice and Humans

    by Sander De Kivit, Eirikur Saeland, Aletta D. Kraneveld, Henk Van De Kant, Bastiaan Schouten, Betty C. Van Esch, Jan Knol, Aline B. Sprikkelman, Leontien B. Van Der Aa, Léon Knippels, et al.